Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

Gold Prices Could Hit ₹1.5 Lakh Per 10 Grams By 2026 Amid Global Economic Uncertainty: Report

Gold Prices Could Hit ₹1.5 Lakh Per 10 Grams By 2026 Amid Global Economic Uncertainty: Report

GST 2.0 Already Boosting Festive Sales, Top Ministers To Highlight Diwali Impact In Dhanteras Press...

GST 2.0 Already Boosting Festive Sales, Top Ministers To Highlight Diwali Impact In Dhanteras Press...

Gold Smuggling Sees Big Spike Before Dhanteras, What’s Fueling This Illegal Rush Amid Record...

Gold Smuggling Sees Big Spike Before Dhanteras, What’s Fueling This Illegal Rush Amid Record...

Havells Q2 Profit Rises 18.86% To ₹318.28 Crore

Havells Q2 Profit Rises 18.86% To ₹318.28 Crore

Govt Extends Application Window PLI Scheme For White Goods Till November 10

Govt Extends Application Window PLI Scheme For White Goods Till November 10